Osteopore Limited and its Controlled Entities Appendix 4D 1. Name of Entity Osteopore Limited (ABN 65 630 538 957) Reporting Period Half-year ended 30 June 2026 Previous Corresponding Reporting Period Half-year ended 30 June 2025 2. Results for Announcement to...
Osteopore: Half Yearly Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Osteopore
- OSX strikes orthopaedic deal for 5 Middle East countries
- Details of Auditor Appointment/Resignation
- OSX completes first Hainan custom orthopaedic implant
- Activities Report June 2026 and Appendix 4C
- OSX secures Hainan FDA approval for orthopaedic devices
Later from Osteopore
- OSX secures market access to Thailand orthopaedic market
- Resignation and appointment of Company Secretary
- Activities Report September 2026 and Appendix 4C
- OSX focuses on Ortho line in Singapore via direct selling
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore